Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucarpidase with HDMTX-LV in Osteosarcoma
NCT00634322Phase 2Terminated
- Sponsor
- Bio-Technology General
- Start
- Oct 2008
- Primary completion
- Mar 2009
- Modality
- Replacement Enzymes
01
Overview
A Phase 2 trial of glucarpidase in osteosarcoma (OS), sponsored by Bio-Technology General. Started Oct 2008; status: terminated.
02
Drugs
glucarpidase
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT00634322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634322.